Heron Therapeutics, Inc.
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −0.02 USD per share, beating the −0.02 USD estimate by 0.00%. Revenue for the same period reached 40.59 M USD, despite the estimate of 39.87 M USD. For the next quarter, analysts expect −0.01 USD in earnings per share and 40.12 M USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise